Atlas Trials

A Clinical Study of ICP-488 in Healthy Subjects and Patients With Psoriasis

Clinical trial NCT05451199 · UNKNOWN

Trial details

NCT number
NCT05451199
Sponsor
Beijing InnoCare Pharma Tech Co., Ltd.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Psoriasis
Start date
2022-07-29
Primary completion
2023-10-30
Enrollment
154

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.